Return to Excellus Employers News

Navigating The GLP-1 Trend

Diabetes is one of the top trend drivers of pharmacy costs due to the growing diabetic population and newer, more expensive therapies recommended earlier in the treatment plan. Since 2006, medications like Ozempic® and Trulicity® have been used to treat Type 2 Diabetes. Today, they are gaining popularity as celebrities and social media influencers tout their weight loss benefits.

As a health plan committed to providing access to high-quality and affordable health care, the rising trend of GLP-1 therapies demands careful consideration.

Read The Full Article

 

 
 
RELATED NEWS:
It’s Time To Report Your 2023 Prescription Data

Target Optical And Pearle Vision Being Added To Vision Network

Why Your Primary Care Provider Matters

Learn How ACQAs Help Increase Quality Care For Members

Reminder Regarding WellNow Urgent Care Provider Status

CATEGORY:

Excellus

Employer

Employer Specific

Small Business

Midsize & Large Business

Wellness

Script for Excellus BCBS Employer/Broker News Archive/Article

 

GDPR Notification Content